Free Biopharma Daily Stock Updates - 3/3/21

Updated: Mar 4

$XBI $139.94 -4.71% 📉

Want to access our searchable database of catalysts and more? Get access to BiopharmIQ for 30 days free, no credit card required. Check it out here!

Covid Updates

$MNOV (-1.75%) Discontinued Covid-19 vaccine development. source


Pipeline Updates

$BTAI (-10.44%) Update on BXCL501 program for dementia, end of phase 2 meeting with FDA scheduled Q2 2021. source

$OVID (+36.49%) Takeda secures rights from Ovid for Soticlestat. source

$ADMA (-1.05%) Kennesaw plasma collection center received FDA approval to implement a Hepatitis B immunization program source

$BPMC (-6.17%) EMA Validation of Type II Variation Marketing Authorization Application for AYVAKYT® (avapritinib) for the Treatment of Advanced Systemic Mastocytosis source

$ORTX (+1.1%) Expansion of Multi-Year Strategic Alliance with Orchard Therapeutics source

$VIR (-27.64%) Update on NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19 source

$PRVB (-4.63%) Proven Publishes data from Teplizumab study source


Financial Updates

$LQDA (-3.43%) Corporation Secures $20.5 Million Debt Facility with Silicon Valley Bank. source

$RDUS (+2.73%) $175 Million Financing Transaction source

$KRTX (-2.54%) Pricing of Public Offering of Common Stock source

0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE